Cameron Durrant

Title: Cameron Durrant: Innovator in Anti-Seizure Therapy

Introduction

Cameron Durrant is a notable inventor based in Califon, NJ (US). He has made significant contributions to the field of medicine, particularly in the development of anti-seizure therapies. With a total of two patents to his name, Durrant's work focuses on innovative compositions that aim to improve patient outcomes.

Latest Patents

Durrant's latest patents include A19-144 and A2-73, which are related to certain anticholinesterase inhibitor compositions and methods for anti-seizure therapy. These inventions concern a dosage form that comprises a therapeutically effective amount of A19-144 or A2-73, along with a therapeutically effective amount of at least one antiepileptic drug (AED). The patents further encompass a method of treating subjects in need of such treatment by administering these compounds in conjunction with any therapeutically effective amount of an AED.

Career Highlights

Throughout his career, Cameron Durrant has worked with Anavex Life Sciences Corporation, where he has contributed to the advancement of therapeutic solutions. His expertise in the field has positioned him as a key player in the development of innovative treatments for neurological conditions.

Collaborations

Durrant has collaborated with Christopher U Missling, enhancing the research and development efforts within the organizations he has been part of.

Conclusion

Cameron Durrant's contributions to anti-seizure therapy through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for innovative treatments that can significantly impact patient care.